Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders

Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders

Junji Saruwatari,1 Hiroo Nakashima,1 Shoko Tsuchimine,2 Miki Nishimura,1 Naoki Ogusu,1 Norio Yasui-Furukori21Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; 2Department of Neuropsychiatry, Graduate School of Medicine, Hiro...

Full description

Bibliographic Details
Main Authors: Saruwatari J, Nakashima H, Tsuchimine S, Nishimura M, Ogusu N, Yasui-Furukori N
Format: Article
Language:English
Published: Dove Medical Press 2014-04-01
Series:Pharmacogenomics and Personalized Medicine
Online Access:http://www.dovepress.com/possible-impact-of-the-cyp2d610-polymorphism-on-the-nonlinear-pharmaco-a16587

Internet

http://www.dovepress.com/possible-impact-of-the-cyp2d610-polymorphism-on-the-nonlinear-pharmaco-a16587

Similar Items